tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DE:1ZLB Stock Latest News

Zai Lab announces new data from preclinical study of ZL-1503
The FlyZai Lab announces new data from preclinical study of ZL-1503
13d ago
ZLAB
Zai Lab Ltd Grants Share Options and Units Under 2024 Equity Plan
PremiumCompany Announcements
Zai Lab Ltd Grants Share Options and Units Under 2024 Equity Plan
21d ago
Promising Oncology Developments and Strategic Insights Drive Buy Rating for Zai Lab
PremiumRatings
Promising Oncology Developments and Strategic Insights Drive Buy Rating for Zai Lab
21d ago
ZLAB
Zai Lab presents updated data from Phase 1a/1b trial evaluating ZL-1310
PremiumThe Fly
Zai Lab presents updated data from Phase 1a/1b trial evaluating ZL-1310
24d ago
ZLAB
Zai Lab receives FDA fast track designation for ZL-1310
PremiumThe Fly
Zai Lab receives FDA fast track designation for ZL-1310
1M ago
ZLAB
Zai Lab’s Growth Amidst Competitive Pressures: Analyst Recommends Hold
PremiumRatingsZai Lab’s Growth Amidst Competitive Pressures: Analyst Recommends Hold
1M ago
ZLAB
Zai Lab Ltd Grants Restricted Share Units to Employees
Premium
Company Announcements
Zai Lab Ltd Grants Restricted Share Units to Employees
1M ago
Zai Lab’s Promising Pipeline and Strategic Advancements Drive Positive Outlook Despite Q1 Revenue Miss
Premium
Ratings
Zai Lab’s Promising Pipeline and Strategic Advancements Drive Positive Outlook Despite Q1 Revenue Miss
2M ago
ZLAB
Zai Lab’s Growth Potential: Strong Revenue Projections and Strategic Positioning Drive Buy Rating
PremiumRatings
Zai Lab’s Growth Potential: Strong Revenue Projections and Strategic Positioning Drive Buy Rating
2M ago
ZLAB
Zai Lab: Hold Rating Amid Mixed Financial Performance and Cautious Outlook
PremiumRatings
Zai Lab: Hold Rating Amid Mixed Financial Performance and Cautious Outlook
2M ago
ZLAB
Zai Lab Reports Strong Q1 2025 Results and Promising Oncology Advances
PremiumCompany Announcements
Zai Lab Reports Strong Q1 2025 Results and Promising Oncology Advances
2M ago
Zai Lab Limited Files Q1 2025 Form 10-Q with SEC
PremiumCompany Announcements
Zai Lab Limited Files Q1 2025 Form 10-Q with SEC
2M ago
Zai Lab reports Q1 EPS (45c), consensus (55c)
PremiumThe FlyZai Lab reports Q1 EPS (45c), consensus (55c)
2M ago
ZLAB
Zai Lab: Strong Pipeline and Strategic Partnerships Drive Buy Rating Despite Revenue Adjustments
Premium
Ratings
Zai Lab: Strong Pipeline and Strategic Partnerships Drive Buy Rating Despite Revenue Adjustments
2M ago
ZLAB
Zai Lab Ltd Announces 2025 Annual General Meeting
Premium
Company Announcements
Zai Lab Ltd Announces 2025 Annual General Meeting
2M ago
Zai Lab presents data from studies evaluating two oncology therapies
PremiumThe Fly
Zai Lab presents data from studies evaluating two oncology therapies
2M ago
ZLAB
Zai Lab to Announce Q1 2025 Results and Host Earnings Call
PremiumCompany Announcements
Zai Lab to Announce Q1 2025 Results and Host Earnings Call
2M ago
Zai Lab: Hold Rating Amid Growth Potential and Competitive Pressures
PremiumRatings
Zai Lab: Hold Rating Amid Growth Potential and Competitive Pressures
2M ago
ZLAB
Zai Lab Prepares for 2025 Annual General Meeting with Proxy Filing
PremiumCompany Announcements
Zai Lab Prepares for 2025 Annual General Meeting with Proxy Filing
2M ago
Zai Lab announces China NMPA acceptance of repotrectinib sNDA
PremiumThe FlyZai Lab announces China NMPA acceptance of repotrectinib sNDA
2M ago
ZLAB
Zai Lab’s Resilience and Promising Pipeline Justify Buy Rating Amid Geopolitical Challenges
Premium
Ratings
Zai Lab’s Resilience and Promising Pipeline Justify Buy Rating Amid Geopolitical Challenges
3M ago
ZLAB
Zai Lab management to meet with Cantor Fitzgerald
Premium
The Fly
Zai Lab management to meet with Cantor Fitzgerald
3M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >